Literature DB >> 28959309

Antimicrobial Effect of Imipenem-Functionalized Fe2O3 Nanoparticles on Pseudomonas aeruginosa Producing Metallo β-lactamases.

Mohammad Reza Khataminejad1, Reza Mirnejad2, Malike Sharif3, Mojtaba Hashemi1, Nikita Sajadi4, Vahhab Piranfar1,2.   

Abstract

BACKGROUND: Resistant strains of Pseudomonas aeruginosa to imipenem was medical treatment problem, especially in burnt units of hospitals.
OBJECTIVES: This study was conducted to evaluate the antimicrobial effect of Fe2O3 nanoparticles alone and functionalized with imipenem on P. aeruginosa starins producing metallo β-lactamases (MBL).
MATERIALS AND METHODS: A disk diffusion method was used to isolate a clinical P. aeruginosa producing Metallo β-lactamases with imipenem resistance. The minimum inhibitory concentration (MIC) of Fe2O3 nanoparticles and imipenem were calculated against the bacteria. The antimicrobial effect of nanoparticles functionalized with the antibiotic was determined. Standard strain of P. aeruginosa ATCC: 27853 was used as control.
RESULTS: The clinical sample was resistant to imipenem (up to 28 μg.mL-1). Similarly, MIC of the nanoparticles against the isolate was 160 μg.mL-1. Subsequently, the combination of 16 pg.mL-1 of antibiotic with 80 μg.mL-1 of Fe2O3 nanoparticles were able to inhibit the growth of the isolate.
CONCLUSIONS: Fe2O3 nanoparticles functionalized with imipenem can impair antibiotic resistance mechanisms of bacteria as it can make the imipenem resistant the aforementioned bacterium more susceptible to weaker concentrations of antibiotic. It also has its own antibacterial effect in certain concentrations.

Entities:  

Keywords:  Fe2O3 nanoparticles ; Antimicrobial properties; Pseudomonas aeruginosa

Year:  2015        PMID: 28959309      PMCID: PMC5492236          DOI: 10.15171/ijb.1138

Source DB:  PubMed          Journal:  Iran J Biotechnol        ISSN: 1728-3043            Impact factor:   1.671


  13 in total

1.  Phenotypic screening of extended-spectrum ß-lactamase and metallo-ß-lactamase in multidrug-resistant Pseudomonas aeruginosa from infected burns.

Authors:  M Vahdani; L Azimi; B Asghari; F Bazmi; A Rastegar Lari
Journal:  Ann Burns Fire Disasters       Date:  2012-06-30

Review 2.  Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.

Authors:  Hui Li; Yi-Feng Luo; Bryan J Williams; Timothy S Blackwell; Can-Mao Xie
Journal:  Int J Med Microbiol       Date:  2012-01-05       Impact factor: 3.473

3.  Nosocomial infections in burn patients: etiology, antimicrobial resistance, means to control.

Authors:  M Leseva; M Arguirova; D Nashev; E Zamfirova; O Hadzhyiski
Journal:  Ann Burns Fire Disasters       Date:  2013-03-31

Review 4.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

5.  Infection control in severely burned patients.

Authors:  Yusuf Kenan Coban
Journal:  World J Crit Care Med       Date:  2012-08-04

6.  Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study.

Authors:  Ameer Azam; Arham S Ahmed; Mohammad Oves; Mohammad S Khan; Sami S Habib; Adnan Memic
Journal:  Int J Nanomedicine       Date:  2012-12-05

7.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

8.  The regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genes.

Authors:  Deepak Balasubramanian; Lisa Schneper; Massimo Merighi; Roger Smith; Giri Narasimhan; Stephen Lory; Kalai Mathee
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

9.  Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea.

Authors:  Jun Sung Hong; Jung Ok Kim; Hyukmin Lee; Il Kwon Bae; Seok Hoon Jeong; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-03-30

10.  Antibiotic Resistance Pattern and Evaluation of Metallo-Beta Lactamase Genes Including bla- IMP and bla- VIM Types in Pseudomonas aeruginosa Isolated from Patients in Tehran Hospitals.

Authors:  Samira Aghamiri; Nour Amirmozafari; Jalil Fallah Mehrabadi; Babak Fouladtan; Hossein Samadi Kafil
Journal:  ISRN Microbiol       Date:  2014-04-23
View more
  3 in total

Review 1.  Nanobiosystems for Antimicrobial Drug-Resistant Infections.

Authors:  Foteini Gkartziou; Nikolaos Giormezis; Iris Spiliopoulou; Sophia G Antimisiaris
Journal:  Nanomaterials (Basel)       Date:  2021-04-22       Impact factor: 5.076

2.  The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa.

Authors:  Mahsa Shahbandeh; Majid Taati Moghadam; Reza Mirnejad; Shiva Mirkalantari; Mehrnaz Mirzaei
Journal:  Int J Nanomedicine       Date:  2020-09-21

Review 3.  Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Elena-Georgiana Dobre; Ilda Czobor Barbu; Roxana Elena Cristian; Marcela Popa; Sang Hee Lee; Carmen Limban; Ilinca Margareta Vlad; Mariana Carmen Chifiriuc
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.